BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 20504927)

  • 1. A vesicular stomatitis virus-based hepatitis B virus vaccine vector provides protection against challenge in a single dose.
    Cobleigh MA; Buonocore L; Uprichard SL; Rose JK; Robek MD
    J Virol; 2010 Aug; 84(15):7513-22. PubMed ID: 20504927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Virus-Like Vesicle-Based Therapeutic Vaccine Vectors for Chronic Hepatitis B Virus Infection.
    Reynolds TD; Buonocore L; Rose NF; Rose JK; Robek MD
    J Virol; 2015 Oct; 89(20):10407-15. PubMed ID: 26246574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterologous prime-boost immunization with vesiculovirus-based vectors expressing HBV Core antigen induces CD8
    Chiale C; Moshkani S; Rose JK; Robek MD
    Antiviral Res; 2019 Aug; 168():156-167. PubMed ID: 31153968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Highly Attenuated Vesicular Stomatitis Virus-Based Vaccine Platform Controls Hepatitis B Virus Replication in Mouse Models of Hepatitis B.
    Moshkani S; Chiale C; Lang SM; Rose JK; Robek MD
    J Virol; 2019 Mar; 93(5):. PubMed ID: 30541859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant vaccinia vector-based vaccine (Tiantan) boosting a novel HBV subunit vaccine induced more robust and lasting immunity in rhesus macaques.
    Deng Y; Chuai X; Chen P; Chen H; Wang W; Ruan L; Li W; Tan W
    Vaccine; 2017 Jun; 35(25):3347-3353. PubMed ID: 28487055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The immune response to a vesicular stomatitis virus vaccine vector is independent of particulate antigen secretion and protein turnover rate.
    Cobleigh MA; Bradfield C; Liu Y; Mehta A; Robek MD
    J Virol; 2012 Apr; 86(8):4253-61. PubMed ID: 22345454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A vesicular stomatitis virus-based therapeutic vaccine generates a functional CD8 T cell response to hepatitis B virus in transgenic mice.
    Cobleigh MA; Wei X; Robek MD
    J Virol; 2013 Mar; 87(5):2969-73. PubMed ID: 23269785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poly(I:C)/alum mixed adjuvant priming enhances HBV subunit vaccine-induced immunity in mice when combined with recombinant adenoviral-based HBV vaccine boosting.
    Chuai X; Chen H; Wang W; Deng Y; Wen B; Ruan L; Tan W
    PLoS One; 2013; 8(1):e54126. PubMed ID: 23335993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nasal route favors the induction of CD4
    Bourgine M; Crabe S; Lobaina Y; Guillen G; Aguilar JC; Michel ML
    Antiviral Res; 2018 May; 153():23-32. PubMed ID: 29510155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection against lethal vaccinia virus challenge by using an attenuated matrix protein mutant vesicular stomatitis virus vaccine vector expressing poxvirus antigens.
    Braxton CL; Puckett SH; Mizel SB; Lyles DS
    J Virol; 2010 Apr; 84(7):3552-61. PubMed ID: 20089648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lasting immune memory against hepatitis B following challenge 10-11 years after primary vaccination with either three doses of hexavalent DTPa-HBV-IPV/Hib or monovalent hepatitis B vaccine at 3, 5 and 11-12 months of age.
    Avdicova M; Crasta PD; Hardt K; Kovac M
    Vaccine; 2015 May; 33(23):2727-33. PubMed ID: 24962750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A fusion DNA vaccine encoding middle version of HBV envelope protein fused to interleukin-21 did not enhance HBV-specific immune response in mice.
    Zhang Y; Su WJ; Wang J; Bai XF; Huang CX; Lian JQ
    Viral Immunol; 2014 Nov; 27(9):430-7. PubMed ID: 25211639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating replication-defective vesicular stomatitis virus as a vaccine vehicle.
    Majid AM; Ezelle H; Shah S; Barber GN
    J Virol; 2006 Jul; 80(14):6993-7008. PubMed ID: 16809305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Longitudinal Hepatitis B Vaccine Cohort Demonstrates Long-lasting Hepatitis B Virus (HBV) Cellular Immunity Despite Loss of Antibody Against HBV Surface Antigen.
    Simons BC; Spradling PR; Bruden DJ; Zanis C; Case S; Choromanski TL; Apodaca M; Brogdon HD; Dwyer G; Snowball M; Negus S; Bruce MG; Morishima C; Knall C; McMahon BJ
    J Infect Dis; 2016 Jul; 214(2):273-80. PubMed ID: 27056956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity of viral vector, prime-boost SIV vaccine regimens in infant rhesus macaques: attenuated vesicular stomatitis virus (VSV) and modified vaccinia Ankara (MVA) recombinant SIV vaccines compared to live-attenuated SIV.
    Van Rompay KK; Abel K; Earl P; Kozlowski PA; Easlick J; Moore J; Buonocore-Buzzelli L; Schmidt KA; Wilson RL; Simon I; Moss B; Rose N; Rose J; Marthas ML
    Vaccine; 2010 Feb; 28(6):1481-92. PubMed ID: 19995539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective anti-hepatitis B virus responses in rhesus monkeys primed with a vectored measles virus and boosted with a single dose of hepatitis B surface antigen.
    Reyes-del Valle J; Hodge G; McChesney MB; Cattaneo R
    J Virol; 2009 Sep; 83(17):9013-7. PubMed ID: 19535451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vesicular Stomatitis Virus-Vectored Multi-Antigen Tuberculosis Vaccine Limits Bacterial Proliferation in Mice following a Single Intranasal Dose.
    Zhang M; Dong C; Xiong S
    Front Cell Infect Microbiol; 2017; 7():34. PubMed ID: 28224119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preclinical evaluation of a two-dose vaccination schedule of recombinant Hansenula polymorpha hepatitis B vaccine in animals.
    Li J; Zhang D; Ma R; Yang X; Wang X; Li C; Zhang S; Xue H; Zhao K; Zhuang H
    Hum Vaccin Immunother; 2013 Apr; 9(4):736-43. PubMed ID: 23370192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Testing of CpG-optimized protein and DNA vaccines against the hepatitis B virus in chimpanzees for immunogenicity and protection from challenge.
    Payette PJ; Ma X; Weeratna RD; McCluskie MJ; Shapiro M; Engle RE; Davis HL; Purcell RH
    Intervirology; 2006; 49(3):144-51. PubMed ID: 16428890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel dendritic-cell-targeting DNA vaccine for hepatitis B induces T cell and humoral immune responses and potentiates the antivirus activity in HBV transgenic mice.
    Yu D; Liu H; Shi S; Dong L; Wang H; Wu N; Gao H; Cheng Z; Zheng Q; Cai J; Zou L; Zou Z
    Immunol Lett; 2015 Dec; 168(2):293-9. PubMed ID: 26475398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.